Back

Stratifying response to omecamtiv mecarbil in HFrEF using multiscale cardiac digital twins

9 May 2026 (15:30 - 16:15)
Organised by: Logo
Congress Presentation Part of: Managing acute heart failure and the end-stage bridge Pharmacotherapy HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Eva Casoni

ELEM Biotech, Barcelona (Spain)

3 More presentations in this session

Presentation thumbnail
Early prediction of prolonged length of stay in heart failure admissions using machine learning models
Mrs X. Zalazar (Atlanta, US)
Abstract Slides Video
Presentation thumbnail
A systematic review and meta-analysis of cardiology-led care Vs general medical care in hospitalised acute decompensated heart failure patients: effects on in-hospital mortality and 30-day readmission
Ms M. Walshe (Kilkenny, IE)
Abstract Slides Video
Presentation thumbnail
STOP-DHF (a non-invasive hemodynamic-guided strategy to prevent heart failure decompensation) trial: preliminary results of medical therapy interventions study
Associate Professor A. Bohm (Bratislava, SK)
Abstract Slides Video

Access the full session

Session thumbnail
Managing acute heart failure and the end-stage bridge

The Event

Event poster

Heart Failure 2026

9 May 2026 15:30 CET
You may be interested in
thumbnail
Congress Presentation
Omecamtiv mecarbil
thumbnail
Congress Session
Novel and targeted therapies: precision pharmacology in heart failure
thumbnail
Congress Presentation
Myotropic drugs

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources